Ezetimibe And Simvastatin Tablet
Product Images NDC 68462-321

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ezetimibe And Simvastatin (NDC 68462-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl 10 10mg30s

Label for Ezetimibe and Simvastatin Tablets 10 mg/10 mg by Glenmark Pharmaceuticals Inc., USA. The package contains 30 oral tablets. The label includes storage instructions, manufacturer details (Glenmark Pharmaceuticals Ltd., India), and contact information with a barcode and NDC 68462-321-30.*

FDA Label Image

Lbl 10 20mg30s

Label for Ezetimibe and Simvastatin Tablets 10 mg/20 mg by Glenmark Pharmaceuticals Inc. The label indicates the product contains 30 tablets, with each tablet including 10 mg ezetimibe and 20 mg simvastatin. It also provides storage instructions, manufacturer information in India, and a barcode. The label notes the product is Rx Only.*

FDA Label Image

Lbl 10 40mg30s

Label for Ezetimibe and Simvastatin Tablets 10 mg/40 mg by Glenmark Pharmaceuticals Inc., USA. The label shows the NDC number 68462-323-30, contains 30 tablets, and notes the product is Rx only. Storage instructions and manufacturing details from Glenmark Pharmaceuticals Ltd. India are included along with contact information.*

FDA Label Image

Lbl 10 80mg30s

Label for Ezetimibe and Simvastatin Tablets 10 mg/80 mg by Glenmark Pharmaceuticals Inc., USA. The label indicates the product is an oral prescription drug, with a package count of 30 tablets. The label includes dosage strength, bar code, and manufacturer information.*

FDA Label Image

Ezetimibe-structure (Ezetimibe Structure)

Chemical structure of the active ingredient ezetimibe and simvastatin shown as a molecular diagram with labeled bonds and hydroxyl groups.*

FDA Label Image

Figure-1 (Figure 1)

A line graph depicting major vascular events as a percentage of patients over five years of follow-up, comparing placebo and ezetimibe and simvastatin treatment groups. The graph shows lower event rates in the ezetimibe and simvastatin group with a statistically significant difference (Logrank P=0.001), including the number of patients at risk for both groups at various time points.*

FDA Label Image

Glenmark-logo (Glenmark Logo)

FDA Label Image

Glenmark-logo1 (Glenmark Logo1)

FDA Label Image

Simva-structure (Simva Structure)

Chemical structure of ezetimibe and simvastatin, showing the molecular arrangement of atoms and bonds typical for this combined active ingredient tablet used for oral administration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.